Roche investor conference call on the acquisition of InterMune
Monday, 25 August
Conference call to discuss the announcement that Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc. (NASDAQ: ITMN) have entered into a definitive merger agreement for Roche to fully acquire InterMune.
The conference call has ended.